nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobutrol—Aphasia—Methotrexate—ankylosing spondylitis	0.0235	0.0235	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.0188	0.0188	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.0173	0.0173	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.0173	0.0173	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.0157	0.0157	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.0157	0.0157	CcSEcCtD
Gadobutrol—Sweating increased—Prednisolone—ankylosing spondylitis	0.0153	0.0153	CcSEcCtD
Gadobutrol—Sweating increased—Triamcinolone—ankylosing spondylitis	0.0141	0.0141	CcSEcCtD
Gadobutrol—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.0141	0.0141	CcSEcCtD
Gadobutrol—Sweating increased—Dexamethasone—ankylosing spondylitis	0.0128	0.0128	CcSEcCtD
Gadobutrol—Sweating increased—Betamethasone—ankylosing spondylitis	0.0128	0.0128	CcSEcCtD
Gadobutrol—Visual impairment—Prednisolone—ankylosing spondylitis	0.0121	0.0121	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.0114	0.0114	CcSEcCtD
Gadobutrol—Sweating increased—Prednisone—ankylosing spondylitis	0.0111	0.0111	CcSEcCtD
Gadobutrol—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.0111	0.0111	CcSEcCtD
Gadobutrol—Visual impairment—Dexamethasone—ankylosing spondylitis	0.0101	0.0101	CcSEcCtD
Gadobutrol—Visual impairment—Betamethasone—ankylosing spondylitis	0.0101	0.0101	CcSEcCtD
Gadobutrol—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00987	0.00987	CcSEcCtD
Gadobutrol—Vertigo—Prednisolone—ankylosing spondylitis	0.00985	0.00985	CcSEcCtD
Gadobutrol—Convulsion—Prednisolone—ankylosing spondylitis	0.0095	0.0095	CcSEcCtD
Gadobutrol—Vertigo—Triamcinolone—ankylosing spondylitis	0.00906	0.00906	CcSEcCtD
Gadobutrol—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00904	0.00904	CcSEcCtD
Gadobutrol—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00895	0.00895	CcSEcCtD
Gadobutrol—Convulsion—Triamcinolone—ankylosing spondylitis	0.00873	0.00873	CcSEcCtD
Gadobutrol—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00872	0.00872	CcSEcCtD
Gadobutrol—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00865	0.00865	CcSEcCtD
Gadobutrol—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00839	0.00839	CcSEcCtD
Gadobutrol—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00823	0.00823	CcSEcCtD
Gadobutrol—Vertigo—Dexamethasone—ankylosing spondylitis	0.00822	0.00822	CcSEcCtD
Gadobutrol—Vertigo—Betamethasone—ankylosing spondylitis	0.00822	0.00822	CcSEcCtD
Gadobutrol—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00821	0.00821	CcSEcCtD
Gadobutrol—Infection—Triamcinolone—ankylosing spondylitis	0.00817	0.00817	CcSEcCtD
Gadobutrol—Infection—Methylprednisolone—ankylosing spondylitis	0.00816	0.00816	CcSEcCtD
Gadobutrol—Insomnia—Prednisolone—ankylosing spondylitis	0.00809	0.00809	CcSEcCtD
Gadobutrol—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00803	0.00803	CcSEcCtD
Gadobutrol—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00795	0.00795	CcSEcCtD
Gadobutrol—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00794	0.00794	CcSEcCtD
Gadobutrol—Convulsion—Betamethasone—ankylosing spondylitis	0.00793	0.00793	CcSEcCtD
Gadobutrol—Convulsion—Dexamethasone—ankylosing spondylitis	0.00793	0.00793	CcSEcCtD
Gadobutrol—Pain—Prednisolone—ankylosing spondylitis	0.00765	0.00765	CcSEcCtD
Gadobutrol—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00747	0.00747	CcSEcCtD
Gadobutrol—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00747	0.00747	CcSEcCtD
Gadobutrol—Insomnia—Triamcinolone—ankylosing spondylitis	0.00744	0.00744	CcSEcCtD
Gadobutrol—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00742	0.00742	CcSEcCtD
Gadobutrol—Infection—Betamethasone—ankylosing spondylitis	0.00742	0.00742	CcSEcCtD
Gadobutrol—Infection—Dexamethasone—ankylosing spondylitis	0.00742	0.00742	CcSEcCtD
Gadobutrol—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00739	0.00739	CcSEcCtD
Gadobutrol—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00737	0.00737	CcSEcCtD
Gadobutrol—Visual impairment—Methotrexate—ankylosing spondylitis	0.00737	0.00737	CcSEcCtD
Gadobutrol—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00734	0.00734	CcSEcCtD
Gadobutrol—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00722	0.00722	CcSEcCtD
Gadobutrol—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00722	0.00722	CcSEcCtD
Gadobutrol—Vertigo—Prednisone—ankylosing spondylitis	0.00716	0.00716	CcSEcCtD
Gadobutrol—Pain—Triamcinolone—ankylosing spondylitis	0.00704	0.00704	CcSEcCtD
Gadobutrol—Convulsion—Prednisone—ankylosing spondylitis	0.0069	0.0069	CcSEcCtD
Gadobutrol—Insomnia—Dexamethasone—ankylosing spondylitis	0.00675	0.00675	CcSEcCtD
Gadobutrol—Insomnia—Betamethasone—ankylosing spondylitis	0.00675	0.00675	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00671	0.00671	CcSEcCtD
Gadobutrol—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.0067	0.0067	CcSEcCtD
Gadobutrol—Paraesthesia—Betamethasone—ankylosing spondylitis	0.0067	0.0067	CcSEcCtD
Gadobutrol—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00659	0.00659	CcSEcCtD
Gadobutrol—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00652	0.00652	CcSEcCtD
Gadobutrol—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.0065	0.0065	CcSEcCtD
Gadobutrol—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.0065	0.0065	CcSEcCtD
Gadobutrol—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00649	0.00649	CcSEcCtD
Gadobutrol—Infection—Prednisone—ankylosing spondylitis	0.00646	0.00646	CcSEcCtD
Gadobutrol—Pain—Betamethasone—ankylosing spondylitis	0.00638	0.00638	CcSEcCtD
Gadobutrol—Pain—Dexamethasone—ankylosing spondylitis	0.00638	0.00638	CcSEcCtD
Gadobutrol—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00628	0.00628	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.0061	0.0061	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.0061	0.0061	CcSEcCtD
Gadobutrol—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00606	0.00606	CcSEcCtD
Gadobutrol—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00605	0.00605	CcSEcCtD
Gadobutrol—Vertigo—Methotrexate—ankylosing spondylitis	0.00598	0.00598	CcSEcCtD
Gadobutrol—Dizziness—Prednisolone—ankylosing spondylitis	0.00592	0.00592	CcSEcCtD
Gadobutrol—Abdominal pain—Betamethasone—ankylosing spondylitis	0.0059	0.0059	CcSEcCtD
Gadobutrol—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.0059	0.0059	CcSEcCtD
Gadobutrol—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.0059	0.0059	CcSEcCtD
Gadobutrol—Body temperature increased—Betamethasone—ankylosing spondylitis	0.0059	0.0059	CcSEcCtD
Gadobutrol—Insomnia—Prednisone—ankylosing spondylitis	0.00588	0.00588	CcSEcCtD
Gadobutrol—Paraesthesia—Prednisone—ankylosing spondylitis	0.00584	0.00584	CcSEcCtD
Gadobutrol—Convulsion—Methotrexate—ankylosing spondylitis	0.00577	0.00577	CcSEcCtD
Gadobutrol—Rash—Prednisolone—ankylosing spondylitis	0.00564	0.00564	CcSEcCtD
Gadobutrol—Dermatitis—Prednisolone—ankylosing spondylitis	0.00564	0.00564	CcSEcCtD
Gadobutrol—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00562	0.00562	CcSEcCtD
Gadobutrol—Headache—Prednisolone—ankylosing spondylitis	0.0056	0.0056	CcSEcCtD
Gadobutrol—Dizziness—Triamcinolone—ankylosing spondylitis	0.00544	0.00544	CcSEcCtD
Gadobutrol—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00543	0.00543	CcSEcCtD
Gadobutrol—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00543	0.00543	CcSEcCtD
Gadobutrol—Infection—Methotrexate—ankylosing spondylitis	0.0054	0.0054	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00532	0.00532	CcSEcCtD
Gadobutrol—Nausea—Prednisolone—ankylosing spondylitis	0.00531	0.00531	CcSEcCtD
Gadobutrol—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00525	0.00525	CcSEcCtD
Gadobutrol—Vomiting—Triamcinolone—ankylosing spondylitis	0.00523	0.00523	CcSEcCtD
Gadobutrol—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00522	0.00522	CcSEcCtD
Gadobutrol—Rash—Triamcinolone—ankylosing spondylitis	0.00519	0.00519	CcSEcCtD
Gadobutrol—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00518	0.00518	CcSEcCtD
Gadobutrol—Rash—Methylprednisolone—ankylosing spondylitis	0.00518	0.00518	CcSEcCtD
Gadobutrol—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00517	0.00517	CcSEcCtD
Gadobutrol—Headache—Triamcinolone—ankylosing spondylitis	0.00515	0.00515	CcSEcCtD
Gadobutrol—Headache—Methylprednisolone—ankylosing spondylitis	0.00514	0.00514	CcSEcCtD
Gadobutrol—Body temperature increased—Prednisone—ankylosing spondylitis	0.00514	0.00514	CcSEcCtD
Gadobutrol—Abdominal pain—Prednisone—ankylosing spondylitis	0.00514	0.00514	CcSEcCtD
Gadobutrol—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00511	0.00511	CcSEcCtD
Gadobutrol—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00511	0.00511	CcSEcCtD
Gadobutrol—Dizziness—Betamethasone—ankylosing spondylitis	0.00494	0.00494	CcSEcCtD
Gadobutrol—Dizziness—Dexamethasone—ankylosing spondylitis	0.00494	0.00494	CcSEcCtD
Gadobutrol—Insomnia—Methotrexate—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Gadobutrol—Nausea—Triamcinolone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Gadobutrol—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Gadobutrol—Nausea—Methylprednisolone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Gadobutrol—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00484	0.00484	CcSEcCtD
Gadobutrol—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00479	0.00479	CcSEcCtD
Gadobutrol—Vomiting—Betamethasone—ankylosing spondylitis	0.00475	0.00475	CcSEcCtD
Gadobutrol—Vomiting—Dexamethasone—ankylosing spondylitis	0.00475	0.00475	CcSEcCtD
Gadobutrol—Rash—Dexamethasone—ankylosing spondylitis	0.00471	0.00471	CcSEcCtD
Gadobutrol—Rash—Betamethasone—ankylosing spondylitis	0.00471	0.00471	CcSEcCtD
Gadobutrol—Dermatitis—Betamethasone—ankylosing spondylitis	0.0047	0.0047	CcSEcCtD
Gadobutrol—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0047	0.0047	CcSEcCtD
Gadobutrol—Headache—Betamethasone—ankylosing spondylitis	0.00468	0.00468	CcSEcCtD
Gadobutrol—Headache—Dexamethasone—ankylosing spondylitis	0.00468	0.00468	CcSEcCtD
Gadobutrol—Pain—Methotrexate—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Gadobutrol—Diarrhoea—Prednisone—ankylosing spondylitis	0.00445	0.00445	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Gadobutrol—Nausea—Betamethasone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Gadobutrol—Nausea—Dexamethasone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Gadobutrol—Dizziness—Prednisone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Gadobutrol—Body temperature increased—Methotrexate—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Gadobutrol—Abdominal pain—Methotrexate—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Gadobutrol—Vomiting—Prednisone—ankylosing spondylitis	0.00413	0.00413	CcSEcCtD
Gadobutrol—Rash—Prednisone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Gadobutrol—Dermatitis—Prednisone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Gadobutrol—Headache—Prednisone—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Gadobutrol—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.004	0.004	CcSEcCtD
Gadobutrol—Nausea—Prednisone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Gadobutrol—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Gadobutrol—Dizziness—Methotrexate—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Gadobutrol—Vomiting—Methotrexate—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Gadobutrol—Rash—Methotrexate—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Gadobutrol—Dermatitis—Methotrexate—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Gadobutrol—Headache—Methotrexate—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Gadobutrol—Nausea—Methotrexate—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
